Screening for toxoplasmosis in pregnancy: What is the evidence of reducing a health problem?

Journal of Medical Screening

Volumn 3, Issue 4, 1996, Pages 188-194

  Eskild, Anne ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Pregnancy; Prevention; Toxoplasmosis

Indexed keywords

ANTIPROTOZOAL AGENT;

CONGENITAL MALFORMATION; CONGENITAL TOXOPLASMOSIS; DISEASE TRANSMISSION; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; INCIDENCE; MASS SCREENING; NEWBORN; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PSYCHOLOGICAL ASPECT; REVIEW; TOXOPLASMOSIS;

ABNORMALITIES; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; MASS SCREENING; MATERNAL-FETAL EXCHANGE; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 0030341602     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1177/096914139600300406     Document Type: Article

References (2)

1. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the foetus and newborn infant. Philadelphia: Saunders, 1990: 89-129.
2. Sever JL, Ellenberg JH, Ley AC, et al. Toxoplamosis: maternai and pediatric findings in 23 000 pregnancies. Pediatrics 1988;82:181-92.